Atyr Pharma Other Current Liabilities

Atyr Pharma (ATYR) currently reports a other current liabilities of $6.7M as of June 2026. That compares with $10M in the prior-year period — down 35.2% year over year. Use the charts on this page to explore Atyr Pharma's other current liabilities history and peer comparisons.

Atyr Pharma's other current liabilities decreased from $10M to $6.7M — a 35.2% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Atyr Pharma reported $6.7M in other current liabilities as of June 2026. That compares with $10M in the prior-year period — down 35.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $6.7M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Atyr Pharma, and consider following ATYR for alerts when major investors trade the stock.

Atyr Pharma is classified in the Healthcare sector. On other current liabilities, it currently shows $6.7M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ATYR with unrelated industries.